Search for:
Author

Philippe Reich

Browsing
Philippe Reich is a partner of Baker McKenzie Switzerland based in Zurich. He serves as head of the Firm's Antitrust, European and International Trade Practice Group in Switzerland. Philippe is a key member of the Firm's International Trade & Commerce and Antitrust & Competition Law Practice Groups. Philippe is regularly ranked as leader in his field in Who's Who Legal and is a recommended practitioner in Legal 500 and Chambers. In 2022, he was ranked among the top 100 foreign lawyers for India related matters. Philippe is also the European representative on the steering committee of Baker McKenzie's Global India Practice, chairman of the Swiss-Indian Chamber of Commerce and forms the India Desk of Baker McKenzie in Switzerland.

After pressure from Parliament, the Swiss Federal Council has against its own intentions opened the consultation process on new legislation to screen foreign investments in future also in Switzerland and has published a draft investment control law (“Draft ICL”). By implementing foreign investment control mechanisms, Switzerland would follow the global trend towards stricter regulation of foreign investments. According to the Draft ICL, the new law would apply to acquisitions of domestic companies by foreign investors. The main objective is the aversion of possible threats to public order and national security resulting from acquisitions of domestic companies by foreign investors. The final aim is to create investment controls in a new and stand-alone federal law.

On 1 August 2022, Swiss National Day, Switzerland’s revised Narcotics Act entered into force. The revision aims at facilitating medical treatments and improving research and development of cannabis. Prior to the revised law, patients and physicians had to apply for special authorization from the Federal Office of Public Health if they wanted to access cannabis for medical purposes. The amendment will allow numerous patients safe and timely access to cannabis medicines as part of their treatment regime. This signifies a further step in modernizing Switzerland’s legislation on cannabis.